Novonix (NVX) Receivables - Other (2021 - 2025)

Novonix (NVX) has reported Receivables - Other for 5 consecutive years, with $758973.0 the latest figure, recorded in Q4 2025.

• Quarterly Receivables - Other rose 65.1% year-over-year to $758973.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $758973.0 (up 65.1% YoY) and the FY2025 annual result came in at $758973.0, up 65.1% from the prior year.
• Receivables - Other improved to $758973.0 in Q4 2025 per NVX's latest filing, from $459718.0 in the prior quarter.
• Over the last five years, Receivables - Other for NVX reached as high as $758973.0 in Q4 2025 and fell as low as $359468.4 in Q2 2021.
• A 5-year average of $501286.2 and a median of $489791.5 in 2022 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2024 — Receivables - Other dropped 13.17% — and 2025, when it surged 65.1%.
• Year by year, Receivables - Other stood at $359468.4 in 2021, then soared by 44.62% to $519865.0 in 2022, then increased by 1.84% to $529436.0 in 2023, then slipped by 13.17% to $459718.0 in 2024, then jumped by 65.1% to $758973.0 in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $758973.0, $459718.0, and $529436.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.